|
|
|
|
|
|
|
COVID-19 and Clinical Trials: The Medidata Perspective White Paper Release 4.0
Access recently released site and patient data
|
|
|
As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata solutions can help address your COVID-19 related challenges. Read our latest report.
New: Results of a global survey of investigator sites about the impact of COVID-19 on their clinical trials Updated: Metrics on patient enrollment by country and therapeutic area (full month data for March and April) Updated: Metrics of Impact of COVID-19 on number of site visits. New: Summary table of the current 8 vaccine clinical trials for COVID-19 New: Launched the COVID-19 Symptom Tracker as part of Medidata’s Patient Portal, myMedidata New: The updated MedDRA 23.0 dictionary supporting new COVID-19 terms and revisions is now available to clients using Rave Coder.
|
|
|
|
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trials, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
|
